- Home
- SVRA vs CATX Comparison
SVRA vs CATX Comparison
Compare SVRA & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- CATX
- Stock Information
- Founded
- SVRA N/A
- CATX 1983
- Country
- SVRA United States
- CATX United States
- Employees
- SVRA N/A
- CATX N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- CATX Medical/Dental Instruments
- Sector
- SVRA Health Care
- CATX Health Care
- Exchange
- SVRA Nasdaq
- CATX Nasdaq
- Market Cap
- SVRA 739.1M
- CATX 782.7M
- IPO Year
- SVRA N/A
- CATX N/A
- Fundamental
- Price
- SVRA $3.65
- CATX $12.13
- Analyst Decision
- SVRA Strong Buy
- CATX Strong Buy
- Analyst Count
- SVRA 5
- CATX 8
- Target Price
- SVRA $12.00
- CATX $22.57
- AVG Volume (30 Days)
- SVRA 1.1M
- CATX 1.2M
- Earning Date
- SVRA 11-07-2024
- CATX 11-12-2024
- Dividend Yield
- SVRA N/A
- CATX N/A
- EPS Growth
- SVRA N/A
- CATX N/A
- EPS
- SVRA N/A
- CATX N/A
- Revenue
- SVRA N/A
- CATX $1,464,000.00
- Revenue This Year
- SVRA N/A
- CATX N/A
- Revenue Next Year
- SVRA N/A
- CATX N/A
- P/E Ratio
- SVRA N/A
- CATX N/A
- Revenue Growth
- SVRA N/A
- CATX 78.32
- 52 Week Low
- SVRA $3.12
- CATX $2.20
- 52 Week High
- SVRA $5.70
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- SVRA 37.33
- CATX 40.10
- Support Level
- SVRA $3.59
- CATX $9.66
- Resistance Level
- SVRA $3.78
- CATX $13.35
- Average True Range (ATR)
- SVRA 0.18
- CATX 0.90
- MACD
- SVRA -0.02
- CATX -0.02
- Stochastic Oscillator
- SVRA 12.50
- CATX 63.33
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.